Leonabio Inc share price logo

Leonabio Inc Share Price

NASDAQ: LONA

Small Cap

$5.56

-0.16

(-2.80%)

Live

as on

Leonabio Inc Stock Performance

as on March 4, 2026 at 6:02 am IST

  • Day's Low

    Day's High

    $5.32
    $5.74
    downward going graph

    4.32%

    Downside

    3.24%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Leonabio Inc share price movements today

Previous Close
$5.72
Open
$5.67
Volume
217.1K
Day's Low - High
$5.32 - $5.74

Leonabio Inc Historical Returns

1 Month Return
+ 23.01 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Leonabio Inc Stock Fundamentals & Key Indicators

Check Leonabio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.6M

EPS (TTM)

-2.895

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-89.42%

Leonabio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Leonabio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Leonabio Inc image
Leonabio Inc
NA$52.6MNANA0.00%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$126.2B133.18%32.4732.94%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$44.2B125.24%142.888.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.1BNA621.555.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$82.6B77.02%18.8331.41%

Leonabio Inc Stock’s Investor Sentiment and Interest

Search interest for Leonabio Inc Stock has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-82% versus previous 30 day period

Leonabio Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
Gross Profit
-
-
0
0
0
Operating Income
-29
-15
-9
-7
-6
EBITDA
-25
-15
-8
-6
-6
Interest Expense
-
-
-
-
-
Depreciation
0
0
0
0
0
Income Before Tax
-28
-15
-9
-6
-6
Income Tax Expense
-
-
-
-
-
Net Income
-28
-15
-9
-6
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Leonabio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
Gross Profit
0
-
-
-
Operating Income
-64
-104
-125
-100
EBITDA
-54
-88
-125
-95
Interest Expense
0
24
-
-
Depreciation
0
0
0
0
Income Before Tax
-54
-95
-117
-96
Income Tax Expense
-
-
-
-
Net Income
-54
-95
-117
-96
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Leonabio Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-32
-27
-26
-26
-28
-15
-9
-6
-6
Operating Cash Flow
-23
-26
-25
-22
-23
-26
-14
-6
-4
Investing Cash Flow
20
6
13
26
18
-2
-7
0
5
Financing Cash Flow
-
0
-
0
0
0
-
0
-
Change in Cash
-3
-19
-12
4
-4
-28
-22
-6
0

Leonabio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-5
-19
-54
-95
-117
-96
Operating Cash Flow
-3
-24
-43
-72
-100
-97
Investing Cash Flow
1
-210
-4
57
95
54
Financing Cash Flow
0
292
97
0
0
0
Change in Cash
-1
58
49
-14
-5
-42

Insights on Leonabio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LONA stock has moved up by 23.0%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LONA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 142.2%

About Leonabio Inc

LeonaBio, Inc., formerly Athira Pharma, Inc., is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). The Company's lead drug candidates, lasofoxifene and ATH-1105, are novel, small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. ATH-1105 is a novel, orally available, brain-penetrant, next-generation small-molecule drug candidate designed to positively modulate the neurotrophic HGF system for potential treatment of neurodegenerative diseases, including ALS, Alzheimer's disease, and Parkinson's disease. Lasofoxifene is a novel, nonsteroidal SERM with a binding profile, designed to confer potent activity against both wild-type and mutant estrogen receptors, including the clinically significant ESR1 mutations.
OrganisationLeonabio Inc
Headquarters18706 North Creek Parkway, Bothell, WA, United States, 98011
CEODr. Mark J. Litton M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Leonabio Inc

Name

Title

Mr. Mark F. Kubik M.B.A.

Chief Business Officer

Dr. Mark J. Litton M.B.A., Ph.D.

President, CEO & Director

Mr. Mark F. Worthington J.D.

General Counsel, Chief Compliance Officer & Corporate Secretary

Dr. Javier San Martin M.D.

Chief Medical Officer

Mr. Robert Renninger

Chief Financial Officer

Dr. Kevin Church Ph.D.

Chief Scientific Officer

Ms. Julie Rathbun

Head of Investor Relations

FAQs

What is Leonabio Inc share price today?

Leonabio Inc share price today is $5.56 as on . Leonabio Inc share today touched a day high of $5.74 and a low of $5.32.

What is the 52 week high and 52 week low for Leonabio Inc share?

Leonabio Inc share touched a 52 week high of $ on and a 52 week low of $ on . Leonabio Inc stock price today i.e. is trending at $5.56,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Leonabio Inc's market capitalisation today?

Leonabio Inc market capitalisation is $0.00T as on .

How to invest in Leonabio Inc Stock (LONA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Leonabio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Leonabio Inc Shares that will get you 0.2698 shares as per Leonabio Inc share price of $5.56 per share as on March 4, 2026 at 12:32 am IST.

What is the minimum amount required to buy Leonabio Inc Stock (LONA) from India?

Indian investors can start investing in Leonabio Inc (LONA) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Leonabio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Leonabio Inc share’s latest price of $5.56 as on March 4, 2026 at 12:32 am IST, you will get 1.7986 shares of Leonabio Inc. Learn more about fractional shares .